[go: up one dir, main page]

FI970696L - Oligonucleotide conjugates, compositions and methods for degrading ribonucleic acids - Google Patents

Oligonucleotide conjugates, compositions and methods for degrading ribonucleic acids Download PDF

Info

Publication number
FI970696L
FI970696L FI970696A FI970696A FI970696L FI 970696 L FI970696 L FI 970696L FI 970696 A FI970696 A FI 970696A FI 970696 A FI970696 A FI 970696A FI 970696 L FI970696 L FI 970696L
Authority
FI
Finland
Prior art keywords
compositions
methods
ribonucleic acids
oligonucleotide conjugates
degrading
Prior art date
Application number
FI970696A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI970696A0 (en
Inventor
Dieter Huesken
Heinz Moser
Robert Haener
Jonathan Hall
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI970696A0 publication Critical patent/FI970696A0/en
Publication of FI970696L publication Critical patent/FI970696L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0042Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI970696A 1994-09-02 1997-02-19 Oligonucleotide conjugates, compositions and methods for degrading ribonucleic acids FI970696L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH269494 1994-09-02
PCT/EP1995/003408 WO1996007667A1 (en) 1994-09-02 1995-08-30 Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids

Publications (2)

Publication Number Publication Date
FI970696A0 FI970696A0 (en) 1997-02-19
FI970696L true FI970696L (en) 1997-02-19

Family

ID=4239485

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970696A FI970696L (en) 1994-09-02 1997-02-19 Oligonucleotide conjugates, compositions and methods for degrading ribonucleic acids

Country Status (8)

Country Link
EP (1) EP0778845A1 (en)
JP (1) JPH10505353A (en)
AU (1) AU3519095A (en)
CA (1) CA2197785A1 (en)
FI (1) FI970696L (en)
HU (1) HUT77034A (en)
NO (1) NO970885L (en)
WO (1) WO1996007667A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798491A (en) * 1993-06-09 1998-08-25 Board Of Regents, The University Of Texas System Multi-mechanistic chemical cleavage using certain metal complexes
US5714328A (en) * 1995-06-07 1998-02-03 Board Of Regents, The University Of Texas System RNA photocleavage using texaphyrins
WO1998007733A1 (en) * 1996-08-20 1998-02-26 Pharmacyclics, Inc. Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof
US6022959A (en) * 1996-08-20 2000-02-08 Pharmacyclics, Inc. Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof
US6255476B1 (en) * 1999-02-22 2001-07-03 Pe Corporation (Ny) Methods and compositions for synthesis of labelled oligonucleotides and analogs on solid-supports
KR101040700B1 (en) * 2006-11-16 2011-06-10 주식회사 엘지화학 Purification method of terephthalaldehyde
NZ580457A (en) 2007-04-06 2012-03-30 Neurocrine Biosciences Inc Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
CL2008000986A1 (en) 2007-04-06 2008-10-17 Neurocrine Biosciences Inc COMPOUND DERIVED FROM NITROGEN HETEROCICLES, GnRH RECEPTOR AGONISTS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE TO TREAT AN AFFECTION RELATED TO SEX HORMONES, ENDOMETRIOSIS, DISMENORREA, OV DISEASE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559207A (en) * 1989-03-06 1996-09-24 Board Of Regents, University Of Texas Texaphyrin metal complex mediated ester hydrolysis

Also Published As

Publication number Publication date
EP0778845A1 (en) 1997-06-18
FI970696A0 (en) 1997-02-19
CA2197785A1 (en) 1996-03-14
NO970885D0 (en) 1997-02-27
JPH10505353A (en) 1998-05-26
AU3519095A (en) 1996-03-27
WO1996007667A1 (en) 1996-03-14
HUT77034A (en) 1998-03-02
NO970885L (en) 1997-04-25

Similar Documents

Publication Publication Date Title
FI962799L (en) Preparation containing nucleic acids, its manufacture and use
HK1012398A1 (en) Phosphonomonoester nucleic acids, methods for their preparation and their use
FI973363L (en) Composition containing nucleic acids, its preparation and use
AU2206800A (en) Targeted molecular bar codes and methods for using the same
EE9500064A (en) Substituted 1H-imidazoles, methods for their preparation, and pharmaceutical compositions
DE69840172D1 (en) RNA EXPORTELEMENT
IL133293A0 (en) Pharmaceutical compositions comprising cyclodextrins
HK1031374A1 (en) Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives.
NL300150I2 (en) 4 "-substituted 9-deoxo-9A-AZA-9A-homoerythromycin-A derivatives.
FI963692L (en) Methods and compositions useful for inhibiting angiogenesis
AU4683099A (en) Targeted oligonucleotide conjugates
FI971176L (en) DNA photocleavage by texapyrins
AU2215995A (en) Freeze-dried compositions comprising rna
DE69529288D1 (en) WATER-SOLUBLE POLYEN CONJUGATES
NO20000231D0 (en) Dolastatin-15 derivatives
PT1042449E (en) MICROORGANISM, PROCESS FOR OBTAINING THE SAME AND ADDITIVE FOR FODDER
DE59811528D1 (en) Hypolipidemic propanolamine derivatives
IL137162A0 (en) 2,3,4,5-tetrahydro -1h- [1,4]-benzodiazepine -3- hydroxamic acids as matrix metalloproteinase inhibitors
FI972264L (en) Betaine product, method for its preparation, and use thereof
FI953578L (en) Xylanase, microorganism producing it, DNA molecule, method for producing xylanase and its use
FI972548A0 (en) Oligonucleotide dendrimerkonjugat
FI970696L (en) Oligonucleotide conjugates, compositions and methods for degrading ribonucleic acids
EE04398B1 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ol, process for their preparation and use as pharmaceuticals
EE03996B1 (en) Pharmaceutical compositions, process for their preparation and use
FI955399L (en) Polyol composition, method for its preparation and uses thereof